NEOMED, GSK, CHUM Research Centre & University College London announced that they have entered into a strategic collaboration to explore the potential of a newly identified target for HIV immune therapy and cure.
Read More
NEOMED, GSK, CHUM Research Centre & University College London announced that they have entered into a strategic collaboration to explore the potential of a newly identified target for HIV immune therapy and cure.
– An analgesic effect demonstrated – – No increase in body temperature nor change in heat pain perception – Montreal, October 30, 2017 – The NEOMED Institute announced today that…